Download PDF
Thromb Haemost 2024; 124(01): 001-003
DOI: 10.1055/s-0043-1778033
Editorial

A Happy New Year 2024 from Thrombosis and Haemostasis!

Gregory Y.H. Lip 
1   Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
2   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Anne Rigby
3   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
,
Christian Weber
3   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
4   German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
5   Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands
› Author Affiliations
› Further Information
   Permissions and Reprints

With our traditional January Editorial and Editors' Choice,[1] we are delighted to welcome you in the New Year! May it be filled with fresh challenges and developments!

Along with our personal and scientific lives, we noted for the first time since 2020 that publications in 2023 clearly moved away from the pandemic scope.[1] While we were relieved to be able to live our lives “normally” again, and were excited to meet our community at meetings, we have learnt along the way. Our Editorial Meeting has now moved to a digital format, allowing more of our Section Editors around the world to take part at the same time and achieve a more productive outcome, while Elinor Switzer from the publisher's team was delighted to meet and catch up with you at the ISTH Thieme Booth last year ([Fig. 1]).

Zoom Image
Fig. 1 Thieme booth at ISTH.


Publication History

Article published online:
11 January 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2023 Editors' choice papers. Thromb Haemost 2024; 124 (01) 81-88
    PubMedGoogle Scholar
  • 2 Corica B, Lobban T, True Hills M, Proietti M, Romiti GF. Sex as a risk factor for atrial fibrillation-related stroke. Thromb Haemost 2023; (e-pub ahead of print). doi: DOI: 10.1055/s-0043-1776394.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Sachetto ATA, Mackman N. Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. Thromb Haemost 2023; 123 (11) 1017-1033
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Akbulut AC, Arisz RA, Baaten CCFMJ. et al. Blood coagulation and beyond: position paper from the Fourth Maastricht Consensus Conference on Thrombosis. Thromb Haemost 2023; 123 (08) 808-839
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Chao TF, Joung B, Takahashi Y. et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost 2022; 122 (01) 20-47
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Gorog DA, Gue YX, Chao TF. et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper. Thromb Haemost 2022; 122 (10) 1625-1652
    Article in Thieme ConnectPubMedGoogle Scholar